Press coverage about Cooper Companies (NYSE:COO) has trended somewhat positive on Saturday, according to Accern Sentiment. The research group ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cooper Companies earned a daily sentiment score of 0.21 on Accern’s scale. Accern also assigned news stories about the medical device company an impact score of 46.2778999444936 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:

Shares of Cooper Companies (NYSE COO) traded up $3.39 during trading on Friday, reaching $242.29. 96,235 shares of the company’s stock were exchanged, compared to its average volume of 311,167. The company has a market capitalization of $11,693.97, a P/E ratio of 25.55, a PEG ratio of 2.05 and a beta of 0.55. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.51 and a quick ratio of 1.29. Cooper Companies has a fifty-two week low of $158.73 and a fifty-two week high of $256.39.

Cooper Companies (NYSE:COO) last announced its earnings results on Thursday, August 31st. The medical device company reported $2.64 EPS for the quarter, topping the Zacks’ consensus estimate of $2.58 by $0.06. The business had revenue of $556.00 million during the quarter, compared to the consensus estimate of $552.32 million. Cooper Companies had a net margin of 16.45% and a return on equity of 16.00%. The firm’s revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the company posted $2.30 earnings per share. equities research analysts predict that Cooper Companies will post 9.72 EPS for the current year.

COO has been the subject of several recent research reports. Robert W. Baird restated a “buy” rating and issued a $273.00 price objective (up from $267.00) on shares of Cooper Companies in a report on Tuesday, September 12th. Zacks Investment Research upgraded Cooper Companies from a “hold” rating to a “buy” rating and set a $277.00 price objective for the company in a report on Tuesday, August 29th. Jefferies Group LLC set a $250.00 price objective on Cooper Companies and gave the company a “buy” rating in a report on Thursday, August 17th. Oppenheimer Holdings, Inc. restated a “hold” rating and issued a $250.00 price objective on shares of Cooper Companies in a report on Tuesday, September 12th. Finally, Cleveland Research restated a “buy” rating on shares of Cooper Companies in a report on Tuesday, August 22nd. Six investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $260.22.

In other Cooper Companies news, Director Gary S. Petersmeyer sold 3,977 shares of the business’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $244.94, for a total value of $974,126.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.60% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Cooper Companies (COO) Stock Price” was posted by Watch List News and is owned by of Watch List News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at https://www.watchlistnews.com/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-cooper-companies-coo-stock-price/1726390.html.

Cooper Companies Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Insider Buying and Selling by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.